Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$748,127,556
+$44,659,058 QoQ
Shares Held
2,945,732
+2.4% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#76
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 8%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $5,952,714,959 across 15 Drug Manufacturers - General names. JNJ ranks #2 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,354,837 | $2,824,462,378 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,945,732 | $748,127,556 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,865,967 | $625,276,759 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,959,269 | $500,214,045 | |
| 5 | ABBV |
AbbVie Inc.
|
1,659,851 | $417,684,905 | |
| 6 | AZN |
Astrazeneca PLC
|
1,320,358 | $250,366,283 | |
| 7 | NVS |
Novartis AG
|
707,061 | $110,810,599 | |
| 8 | GSK |
GSK plc
|
1,838,479 | $96,373,069 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $748,127,556 | 2,945,732 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $703,468,498 | 2,877,878 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $723,323,568 | 3,495,161 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $830,919,864 | 4,481,285 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,029,809,186 | 6,741,795 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,098,503,595 | 6,623,876 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,087,296,690 | 7,518,301 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,172,027,967 | 7,232,062 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,171,357,372 | 8,014,213 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $1,198,538,557 | 7,576,576 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,122,225,954 | 7,159,793 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,008,895,545 | 6,477,660 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,235,166,020 | 7,462,337 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,102,181,595 | 7,110,849 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,194,084,046 | 6,759,604 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,104,585,431 | 6,761,664 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,195,931,022 | 6,737,260 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,295,792,687 | 7,311,362 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,394,866,460 | 8,153,776 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $1,290,444,109 | 7,990,366 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,328,596,140 | 8,064,806 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $1,331,882,539 | 8,103,940 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,321,313,220 | 8,395,687 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,096,066,768 | 7,362,082 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,043,462,365 | 7,419,913 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $931,060,240 | 7,100,284 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||